However, the specific mechanisms of ghrelin O-acyltransferase inhibitors need to be further investigated because it is important for research on how to treat obesity caused by pathological metabolic abnormalities, as well as for the development of new targets for weight loss drugs. This evidence concerns the gene GHRL and obesity disorder.